2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Subclinical pulmonary embolism in first-line/induction therapy of lung cancer - a remaining clinically relevant adverse event
Introduction Pulmonary embolism (PE) at initial diagnosis and during first-line systemic treatment is clinically relevant in patients with lung cancer. However, real-world incidence of subclinical PE is not well established. Methods Retrospective single-center analysis of patients at least 18 years old with non-small-c...